| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK J2 |
|---|
| Description | Inactive control of GSK J1 (IC50 > 100 μM for inhibition of JMJD3/UTX). Cell permeable ester derivative, GSK J5 and Active Analog also available.. Purity 98%. MW (observed): 389.45 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[2-(3-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester |
|---|
| Gene, Accession, CAS # | CAS: 1394854-52-4 |
|---|
| Catalog # | 4688/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK J2 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|